🚀 VC round data is live in beta, check it out!
- Public Comps
- AOTI
AOTI Valuation Multiples
Discover revenue and EBITDA valuation multiples for AOTI and similar public comparables like Anatolia Geneworks, Svas Biosana, Envoy Medical, SMAIO and more.
AOTI Overview
About AOTI
AOTI Inc produces, rents, and sells medical devices to help resolve severe acute and chronic wounds for customers globally. The company provides efficacious topical wound oxygen solutions for use in both the institutional and the home care setting to improve the health, well-being, and independence of patients. Its products include TWO2 Extremity Chamber, TWO2 Multi-Patch.
Founded
2008
HQ

Employees
N/A
Website
Financials (FY)
EV
$63M
AOTI Financials
AOTI reported last fiscal year revenue of $58M and EBITDA of $3M.
In the same fiscal year, AOTI generated $51M in gross profit, $3M in EBITDA, and had net loss of ($2M).
AOTI P&L
In the most recent fiscal year, AOTI reported revenue of $58M and EBITDA of $3M.
AOTI expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $58M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $51M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 88% | XXX | XXX | XXX |
| EBITDA | — | XXX | $3M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 5% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 2% | XXX | XXX | XXX |
| Net Profit | — | XXX | ($2M) | XXX | XXX | XXX |
| Net Margin | — | XXX | (3%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
AOTI Stock Performance
AOTI has current market cap of $55M, and enterprise value of $63M.
Market Cap Evolution
AOTI's stock price is $0.52.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $63M | $55M | 0.0% | XXX | XXX | XXX | $-0.02 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAOTI Valuation Multiples
AOTI trades at 1.1x EV/Revenue multiple, and 23.9x EV/EBITDA.
AOTI Financial Valuation Multiples
As of April 20, 2026, AOTI has market cap of $55M and EV of $63M.
Equity research analysts estimate AOTI's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
AOTI has a P/E ratio of (31.5x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $55M | XXX | $55M | XXX | XXX | XXX |
| EV (current) | $63M | XXX | $63M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 1.1x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 23.9x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 50.2x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 1.2x | XXX | XXX | XXX |
| P/E | — | XXX | (31.5x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (8.0x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified AOTI Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


AOTI Margins & Growth Rates
AOTI's revenue in the last fiscal year grew by 33%.
AOTI Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 33% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 5% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (162%) | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 86% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
AOTI Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| AOTI | XXX | XXX | XXX | XXX | XXX | XXX |
| Anatolia Geneworks | XXX | XXX | XXX | XXX | XXX | XXX |
| Svas Biosana | XXX | XXX | XXX | XXX | XXX | XXX |
| Envoy Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| SMAIO | XXX | XXX | XXX | XXX | XXX | XXX |
| Tobii | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
AOTI M&A Activity
AOTI acquired XXX companies to date.
Last acquisition by AOTI was on XXXXXXXX, XXXXX. AOTI acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by AOTI
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialAOTI Investment Activity
AOTI invested in XXX companies to date.
AOTI made its latest investment on XXXXXXXX, XXXXX. AOTI invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by AOTI
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout AOTI
| When was AOTI founded? | AOTI was founded in 2008. |
| Where is AOTI headquartered? | AOTI is headquartered in United States. |
| Who is the CEO of AOTI? | AOTI's CEO is Michael Stephen Griffiths. |
| Is AOTI publicly listed? | Yes, AOTI is a public company listed on London Stock Exchange. |
| What is the stock symbol of AOTI? | AOTI trades under AOTI ticker. |
| When did AOTI go public? | AOTI went public in 2024. |
| Who are competitors of AOTI? | AOTI main competitors are Anatolia Geneworks, Svas Biosana, Envoy Medical, SMAIO. |
| What is the current market cap of AOTI? | AOTI's current market cap is $55M. |
| What is the current revenue of AOTI? | AOTI's last fiscal year revenue is $58M. |
| What is the current EV/Revenue multiple of AOTI? | Current revenue multiple of AOTI is 1.1x. |
| Is AOTI profitable? | No, AOTI is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.